Bigul

Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 Of SEBI Listing Regulations

Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday, November 14, 2022, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2022, amongst other matters. Further, as per provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed from Saturday, October 1, 2022, upto Wednesday, November 16, 2022 (both days inclusive). This is for your kind information and record purposes.
07-11-2022
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November 04, 2022 for Pronomz Ventures LLP
04-11-2022
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation pursuant to Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
21-10-2022
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation pursuant to Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
19-10-2022
Bigul

Strides Pharma Science Ltd - 532531 - Statement Of Investor Complaints For The Quarter Ended September 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 014131 Name of the Signatory :- Manjula RamamurthyDesignation :- Company Secretary and Compliance Officer
19-10-2022
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 29, 2022 for Arunkumar Pillai
30-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 27, 2022 for Shasun Leasing and Finance Pvt Ltd
27-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment

Allotment of 1,50,830 equity shares of face value of Rs. 10/- each to M/s. Karuna Business Solutions LLP (Warrant Holder) upon conversion of equivalent number of warrants to equity shares
16-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We would like to inform you that the Company has completed the procedural requirements and dispatched the 'Letter of Confirmation' (LoC) to the following Shareholder as prescribed under SEBI Circular SEBI/ HO/ MIRSD/ MIRSD_RTAMB/ P/ CIR/ 2022/8 of January 25, 2022. Veera Reddy Palagiri
15-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
10-09-2022
Next Page
Close

Let's Open Free Demat Account